Literature DB >> 6838433

Enhanced macrophage degradation of biologically modified low density lipoprotein.

T Henriksen, E M Mahoney, D Steinberg.   

Abstract

Low density lipoprotein (LDL) conditioned by incubation in the presence of rabbit aortic or human umbilical vein endothelial cells (endothelial cell-modified LDL) was degraded by macrophages three to five times more rapidly than LDL incubated in the absence of cells (control LDL). This enhanced degradation occurred mostly via a high affinity, saturable pathway related to the pathway for macrophage uptake of acetylated LDL. Conditioning LDL with cultured aortic smooth muscle cells had a qualitatively similar but smaller effect; conditioning with fibroblasts had no effect. Conditioning very low density lipoproteins or high density lipoproteins with endothelial cells did not affect subsequent metabolism of these lipoproteins by macrophages. Endothelial cell-modified LDL, while degraded more rapidly than control LDL by macrophages, was degraded more slowly by cultured smooth muscle cells and by human skin fibroblasts. Degradation of endothelial cell-modified LDL by macrophages was accompanied by stimulation of cholesterol esterification, inhibition of cholesterol synthesis, and a net increment in total cellular cholesterol content. Thus, a biologically generated modification of LDL is described that markedly alters cholesterol metabolism of macrophages and, consequently, may play a role in foam cell formation during atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838433     DOI: 10.1161/01.atv.3.2.149

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  65 in total

Review 1.  Did the antioxidant trials fail to validate the oxidation hypothesis?

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; B V Khan; N Santanam
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

Review 2.  Oxidative stress in cardiovascular disease.

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; N Santanam
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

3.  Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.

Authors:  O Jaakkola; T Nikkari
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

Review 4.  Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation.

Authors:  S Chatterjee
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

5.  Tandem mass spectrometric characterization of a specific cysteic acid residue in oxidized human apoprotein B-100.

Authors:  O Burlet; C Y Yang; J R Guyton; S J Gaskell
Journal:  J Am Soc Mass Spectrom       Date:  1995-04       Impact factor: 3.109

Review 6.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

7.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

Authors:  A D Watson; J A Berliner; S Y Hama; B N La Du; K F Faull; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

8.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; E Wieland; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

9.  Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.

Authors:  S Christen; S R Thomas; B Garner; R Stocker
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.